SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 147 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $387,000 | +184.6% | 27,538 | +31.5% | 0.02% | +233.3% |
| Q1 2017 | $136,000 | -89.9% | 20,938 | -89.8% | 0.01% | -91.0% |
| Q2 2016 | $1,351,000 | +91.4% | 205,678 | +85.2% | 0.07% | +109.4% |
| Q1 2016 | $706,000 | -24.9% | 111,078 | -28.8% | 0.03% | -28.9% |
| Q4 2015 | $940,000 | +229.8% | 155,978 | +227.2% | 0.04% | +309.1% |
| Q3 2015 | $285,000 | -23.0% | 47,668 | -12.1% | 0.01% | -8.3% |
| Q2 2015 | $370,000 | -43.9% | 54,228 | -43.0% | 0.01% | -52.0% |
| Q4 2014 | $659,000 | +125.7% | 95,095 | +164.6% | 0.02% | +92.3% |
| Q3 2014 | $292,000 | -66.6% | 35,945 | -66.5% | 0.01% | -71.1% |
| Q2 2014 | $873,000 | -19.5% | 107,441 | -22.3% | 0.04% | -21.1% |
| Q1 2014 | $1,084,000 | +10.6% | 138,341 | +24.8% | 0.06% | +9.6% |
| Q4 2013 | $980,000 | +116.3% | 110,835 | +104.9% | 0.05% | +108.0% |
| Q3 2013 | $453,000 | -73.4% | 54,091 | -76.3% | 0.02% | -55.4% |
| Q2 2013 | $1,702,000 | – | 228,215 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |